Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | OT |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | OT |
FBE calling on behalf of an HCP to report that a female patient in her 20's took her first dose of GARDASIL-9 "a few months ago" and experienced bilateral tingling and numbness in her fingers and hands that lasted "a day or two". Patient did not re; numbness in her fingers; This spontaneous report was received from a nurse practitioner and refers to an adult female patient (in her 20's). The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date (reported as a "few months ago"), the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), dose number 1, administered by Intramuscular route (lot # and expiration date were not reported). On 25-Apr-2025 (reported as "today"), the patient was vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), dose number 2, administered by Intramuscular route (lot # and expiration date were not reported); both doses as prophylaxis. On an unknown date, the patient experienced bilateral tingling and numbness in her fingers and hands that lasted "a day or two". The patient did not report the issues until a few months later when she went back for her 2nd dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9). After the administration of the second dose, the patient informed the doctor of the experience with numbness and tingling on the prior dose and confirmed that she did not seek medical treatment at the time of the event. Patient has not reported any symptoms with second dose. The causal relationship between the event of bilateral tingling and numbness in her fingers and hands and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was not provided.